Martingale Asset Management L P lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 330,634 shares of the healthcare conglomerate’s stock after selling 105,312 shares during the period. UnitedHealth Group makes up about 0.8% of Martingale Asset Management L P’s holdings, making the stock its 10th largest position. Martingale Asset Management L P’s holdings in UnitedHealth Group were worth $54,228,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Dodge & Cox acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $1,658,560,000. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $1,530,177,000. Harris Associates L P raised its position in UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock worth $762,041,000 after buying an additional 14,489 shares during the last quarter. UBS Asset Management Americas Inc. raised its position in UnitedHealth Group by 6.2% in the first quarter. UBS Asset Management Americas Inc. now owns 4,372,898 shares of the healthcare conglomerate’s stock worth $717,199,000 after buying an additional 255,799 shares during the last quarter. Finally, American Century Companies Inc. raised its position in UnitedHealth Group by 9.0% in the first quarter. American Century Companies Inc. now owns 4,022,002 shares of the healthcare conglomerate’s stock worth $659,649,000 after buying an additional 333,338 shares during the last quarter. 86.21% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Incorporated (UNH) traded down 0.65% during trading on Wednesday, hitting $193.23. The stock had a trading volume of 1,056,809 shares. The company’s 50 day moving average is $189.87 and its 200 day moving average is $175.41. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04. The firm has a market cap of $186.83 billion, a PE ratio of 23.21 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. The business had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.96 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s payout ratio is presently 35.13%.
ILLEGAL ACTIVITY NOTICE: “Martingale Asset Management L P Sells 105,312 Shares of UnitedHealth Group Incorporated (UNH)” was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://stocknewstimes.com/2017/08/16/unitedhealth-group-incorporated-unh-position-lowered-by-martingale-asset-management-l-p-updated.html.
UNH has been the subject of several research reports. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. Deutsche Bank AG reissued a “buy” rating and issued a $187.00 target price (up previously from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Mizuho increased their target price on UnitedHealth Group from $178.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday, April 18th. Vetr raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 target price for the company in a research report on Tuesday, May 30th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $208.00 target price on shares of UnitedHealth Group in a research report on Friday, July 21st. One investment analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $202.20.
In other news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now directly owns 76,058 shares in the company, valued at $14,753,730.84. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,540 shares of company stock worth $2,873,320. Insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
